LTV1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.916000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.780950E-01
Normal-vs-Stage2
6.042300E-02
Normal-vs-Stage3
9.235500E-02
Normal-vs-Stage4
6.395400E-01
Stage1-vs-Stage2
8.993600E-01
Stage1-vs-Stage3
4.603600E-01
Stage1-vs-Stage4
2.632200E-01
Stage2-vs-Stage3
3.141600E-01
Stage2-vs-Stage4
1.718950E-01
Stage3-vs-Stage4
8.714400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.425800E-02
Normal-vs-AfricanAmerican
4.891800E-01
Normal-vs-Asian
3.737800E-02
Caucasian-vs-AfricanAmerican
2.012600E-01
Caucasian-vs-Asian
1.950640E-01
AfricanAmerican-vs-Asian
6.378200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.354200E-02
Normal-vs-Female
1.184750E-01
Male-vs-Female
2.461200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.550190E-01
Normal-vs-Age(41-60Yrs)
8.830100E-02
Normal-vs-Age(61-80Yrs)
6.145500E-02
Normal-vs-Age(81-100Yrs)
1.381390E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.934200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.294200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.592600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.074800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.521400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.473200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.311630E-02
Normal-vs-Daily Drinker
3.244500E-02
Normal-vs-Weekly Drinker
5.079000E-01
Normal-vs-Occasional Drinker
2.082300E-02
Normal-vs-Social Drinker
1.241170E-01
Non Drinker-vs-Daily Drinker
6.214800E-01
Non Drinker-vs-Weekly Drinker
1.744370E-01
Non Drinker-vs-Occasional Drinker
3.376800E-01
Non Drinker-vs-Social Drinker
1.877160E-01
Daily Drinker-vs-Weekly Drinker
8.540400E-02
Daily Drinker-vs-Occasional Drinker
2.027600E-01
Daily Drinker-vs-Social Drinker
1.495970E-01
Weekly Drinker-vs-Occasional Drinker
3.521600E-01
Weekly Drinker-vs-Social Drinker
5.518400E-01
Occasional Drinker-vs-Social Drinker
5.970200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.077000E-01
Normal-vs-Grade 2
8.093200E-01
Normal-vs-Grade 3
8.076400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.602600E-01
Grade 1-vs-Grade 3
9.979400E-01
Grade 1-vs-Grade 4
8.077000E-01
Grade 2-vs-Grade 3
9.555000E-01
Grade 2-vs-Grade 4
8.093200E-01
Grade 3-vs-Grade 4
8.076400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.709900E-02
Normal-vs-NonDiabetic
3.623600E-02
Diabetic-vs-NonDiabetic
7.600800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.382000E-03
Normal-vs-NoPancreatitis
4.821900E-02
Pancreatitis-vs-NoPancreatitis
1.152350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.296200E-02
Normal-vs-N1
6.069700E-02
N0-vs-N1
9.337400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.244100E-02
Normal-vs-TP53-NonMutant
1.852000E-01
TP53-Mutant-vs-TP53-NonMutant
1.750570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
